Organogenesis Holdings Inc.
ORGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 49.7% | 16.2% | -31.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76% | 72.6% | 72.6% | 75.5% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 18.1% | -6.2% | -18.3% | 11.6% |
| Net Income | $0 | -$0 | -$0 | $0 |
| % Margin | 14.3% | -9.3% | -21.7% | 6.1% |
| EPS Diluted | 0.11 | -0.096 | -0.17 | 0.058 |
| % Growth | 214.3% | 43.4% | -392.6% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |